Table 2 Bibliographic information included primary studies
From: Systematic review and meta-analysis: diagnostic accuracy of exosomes in pancreatic cancer
Title | First author | Year | County | Ref. | |
|---|---|---|---|---|---|
1 | CD63-positive extracellular vesicles are potential diagnostic biomarkers of pancreatic ductal adenocarcinoma. | Haruki Odaka | 2022 | Japan | [12] |
2 | Glypican1 identifies cancer exosomes and facilitates early detection of cancer. | Sonia A. Melo | 2022 | USA | [13] |
3 | Highly Sensitive Exosome Detection for Early Diagnosis of Pancreatic Cancer Using Immunoassay Based on Hierarchical Surface-Enhanced Raman Scattering Substrate | Juan Li | 2022 | China | [14] |
4 | Exosomal circular RNA hsa_circ_0006220, and hsa_circ_0001666 as biomarkers in the diagnosis of pancreatic cancer | Lu Hong | 2022 | China | [15] |
5 | Exosomal glypican-1 discriminates pancreatic ductal adenocarcinoma from chronic pancreatitis. | P.Moutinho-Ribeiro | 2022 | Portugal | [16] |
6 | Serum exosomal miR-451a acts as a candidate marker for pancreatic cancer | Jia Chen | 2022 | China | [17] |
7 | Circulating cancer-associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer | Yusuke Yoshioka | 2022 | Japan | [18] |
8 | Dual Tumor Exosome Biomarker Corecognitions Based Nanoliquid Biopsy for the Accurate Early Diagnosis of Pancreatic Cancer | Zhiguo Yu | 2023 | China | [19] |
9 | MicroRNA-20a in extracellular vesicles derived from duodenal fluid is a possible biomarker for pancreatic ductal adenocarcinoma. | Takashi Taniguchi | 2024 | Japan | [20] |